Genotype predicts heart failure independent of left ventricular ejection fraction and NT-proBNP levels in hypertrophic cardiomyopathy

被引：0
|
作者：
Bakalakos, A. [1 ]
Protonotarios, A. [1 ]
Coats, C. J. [2 ]
Monda, E. [1 ]
Cannie, D. E. [1 ]
O'Mahony, C. [1 ]
Syrris, P. [1 ]
Lorenzini, M. [1 ]
Elliott, P. M. [1 ]
机构：
[1] UCL, Inst Cardiovasc Sci, London, England
[2] Queen Elizabeth Univ Hosp, Glasgow, Scotland
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2046
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Paradoxical decrease in plasma N-Terminal-proBNP (NT-proBNP) levels in patients receiving doxorubicin chemotherapy and declining left ventricular ejection fraction
    Bhatheja, R
    Taneja, D
    Bakhru, M
    Tang, W
    Francis, GS
    Van Lente, F
    Jin, T
    Howard, D
    Budd, GT
    Pohlman, B
    Andresen, S
    Weng, DE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 66A - 66A
  • [42] NT-proBNP: An independent predictor of heart failure in the heart and soul study
    Bibbins-Domingo, K.
    Na, B.
    Gupta, R.
    Wu, A. H.
    Schiller, N. B.
    Whooley, M. A.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 : 92 - 92
  • [43] Correlation Between Body Mass Index and NT-proBNP Levels in Heart Failure With Preserved Ejection Fraction: Implications for Clinical Outcomes
    Vungarala, Soumya
    Jani, Vivek
    Vaishnav, Joban
    Hahn, Virginia S.
    Kass, David A.
    Sharma, Kavita
    CIRCULATION, 2023, 148
  • [44] Baseline NT-proBNP and responsiveness to autonomic regulation therapy in patients with heart failure and reduced ejection fraction
    Anand, Inder
    Ardell, Jeffrey L.
    Gregory, Doug
    Libbus, Imad
    DiCarlo, Lorenzo
    Premchand, Rajendra K.
    Sharma, Kamal
    Mittal, Sanjay
    Monteiro, Rufino
    IJC HEART & VASCULATURE, 2020, 29
  • [45] Vericiguat and NT-proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial
    Senni, Michele
    Lopez-Sendon, Jose
    Cohen-Solal, Alain
    Ponikowski, Piotr
    Nkulikiyinka, Richard
    Freitas, Cecilia
    Vlajnic, Vanja Miodrag
    Roessig, Lothar
    Pieske, Burkert
    ESC HEART FAILURE, 2022, 9 (06): : 3791 - 3803
  • [46] SACUBITRIL / VALSARTAN IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: COMPARATIVE PROFILE OF NT-PROBNP AND BNP
    Ajello, L.
    Romano, G.
    Agnese, V.
    Bellavia, D.
    Di Gesaro, G.
    Falletta, C.
    La Franca, E.
    Mina, C.
    Storniolo, S.
    Clemenza, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E223 - E224
  • [47] INTERLEUKIN-1 BLOCKADE REDUCES NT-PROBNP SERUM LEVELS IN PATIENTS WITH STABLE HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Trankle, Cory
    Canada, Justin
    Carbone, Salvatore
    Buckley, Leo
    Del Buono, Marco Giuseppe
    Christopher, Sanah
    Kadariya, Dinesh
    Vo, Chau
    Abouzaki, Nayef
    Arena, Ross
    Van Tassell, Benjamin
    Abbate, Antonio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 869 - 869
  • [48] Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction
    Buckley, Leo F.
    Canada, Justin M.
    Del Buono, Marco G.
    Carbone, Salvatore
    Trankle, Cory R.
    Billingsley, Hayley
    Kadariya, Dinesh
    Arena, Ross
    Van Tassell, Benjamin W.
    Abbate, Antonio
    ESC HEART FAILURE, 2018, 5 (02): : 372 - 378
  • [49] Relationship Between Myocardial NPPB Expression and Serum NT-proBNP in Heart Failure With Preserved Ejection Fraction
    Hahn, Virginia S.
    Knutsdottir, Hildur
    Peterson, Tess E.
    Kikuchi, Daniel
    Vungarala, Soumya
    Kass, David A.
    JACC-HEART FAILURE, 2024, 12 (07) : 1306 - 1308
  • [50] Humanin Level is Inversely Correlated with NT-proBNP Level and Mortality in Heart Failure with Reduced Ejection Fraction
    Yan, Crystal
    Grazette, Luanda
    CIRCULATION, 2024, 150
12345